Valentine Capital Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Valentine Capital Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.06M	Sell	18,270 -3,085	-14%	-$332K	2.3%	12
2015 Q3	$2.16M	Sell	21,355 -6,100	-22%	-$725K	1.91%	15
2015 Q2	$3.4M	Sell	27,455 -20,990	-43%	-$2.53M	2.29%	9
2015 Q1	$5.73M	Sell	48,445 -11,190	-19%	-$1.27M	1.67%	16
2014 Q4	$6.08M	Sell	59,635 -13,355	-18%	-$1.3M	1.48%	21
2014 Q3	$6.7M	Sell	72,990 -305	-0.4%	-$26.5K	2.58%	13
2014 Q2	$6.03M	Sell	73,295 -12,900	-15%	-$986K	1.16%	32
2014 Q1	$6.61M	Buy	86,195 +23,195	+37%	+$1.81M	1.37%	24
2013 Q4	$4.36M	Buy	63,000 +1,830	+3%	+$120K	0.93%	45
2013 Q3	$3.96M	Buy	61,170 +2,660	+5%	+$168K	1.04%	37
2013 Q2	$3.4M	Buy	+58,510	New	+$3.34M	1.06%	34

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Valentine Capital Asset Management's FBT Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 14% in Q4 2015, selling an estimated $332K and leaving 18,270 shares worth $2.06M. The position accounts for 2.3% of the portfolio, ranked #12.

Valentine Capital Asset Management first reported a position in FBT in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.7M in Q3 2014. 129 funds tracked by Wall St. Rank hold FBT as of Q4 2015.

Valentine Capital Asset Management held 18,270 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.06M as of Q4 2015.
Valentine Capital Asset Management sold 3,085 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2015, an estimated $332K.
First Trust NYSE Arca Biotechnology Index Fund made up 2.3% of Valentine Capital Asset Management's portfolio in Q4 2015, its #12 holding.
Valentine Capital Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 11 quarters since.
Valentine Capital Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $6.7M in Q3 2014.
129 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.